Cytokines and costimulatory molecules as genetic adjuvants

Immunology and Cell Biology

Volumn 75, Issue 4, 1997, Pages 397-401

  Pasquini, S ^a   Xiang, Z ^a   Wang, Y ^a   He, Z ^a   Deng, H ^a   Blaszczyk Thurin, M ^a   Ertl, H C J ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Adjuvants; Costimulatory molecules; Cytokines; Genetic vaccines

Indexed keywords

CYTOKINE; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4;

ANTIGEN PRESENTING CELL; CANCER; EXPRESSION VECTOR; GENE TECHNOLOGY; HELPER CELL; IMMUNOMODULATION; INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; REVIEW; VACCINATION;

ANIMALIA;

EID: 0030968562     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.62     Document Type: Review

References (37)

1. Tang D, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356: 152-4.
2. Wang B, Merva M, Dang K, Ugen K, Williams WV, Weiner DB. Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Hum. Gene Ther. 1995; 6: 407-18.
3. Wolff JA, Ludtke JJ, Ascadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1992; 1: 363-9.
4. Wolff JA, Williams P, Ascadi G, Jiao S, Jani A, Chong W. Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 1991; 11: 474-85.
5. Stevenson FK, Zhu D, King CA et al. A genetic approach to idiotypic vaccination for B cell lymphoma. Ann. N.Y. Acad. Sci. 1995; 772: 212-26.
6. Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993; 11: 957-60.
7. Donnelly JJ, Friedman A, Montgomery D et al. Polynucleotide vaccination against influenza p55. In: Norrby E, Brown F, Chancock RM, Ginsberg HS (eds). Vaccine 94. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1994; 55-9.
8. McClements WL, Armstrong ME, Keys RD, Liu M. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B alone or in combination induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl Acad. Sci. USA 1996; 93: 11 414-20.
9. Xiang ZQ, Spitalnik SL, Cheng J, Erikson J, Wojczyk B, Ertl HCJ. Immune responses to nucleic acid vaccines to rabies virus. Virology 1995; 209: 569-79.
10. Kumar V, Sercarz E. Genetic vaccination: The advantages of going naked. Nat. Med. 1996; 2: 857-9.
11. Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-9.
12. Pertmer TM, Roberts TR, Haynes JR. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 1996; 70: 6119-25.
13. Dixon B. The third vaccine revolution. Biotechnology 1995; 13: 420.
14. Barrios C, Brandt C, Berney M et al. Partial correction of the Th2/Th1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur. J. Immunol. 1996; 26: 2666-70.
15. Raz E, Watanabe A, Baird SM et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl Acad. Sci. USA 1993; 90: 4523-7.
16. Sun WH, Burkholder JK, Sun J et al. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl Acad. Sci. USA 1995; 92: 2889-93.
17. Allione A, Consalvo M, Nanni P et al. Immunizing and curative potential of replicating and non-replicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10. tumor necrosis factor α, granulocyte-macrophage colony stimulating factor, and γ-interferon gene or admixed with conventional adjuvants. Cancer Res. 1994; 54: 6022-6.
18. Xiang ZQ, Ertl HCJ. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 1995; 2: 129-35.
19. Nikcevich KM, Gordon KB, Tan L et al. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 1997; 158: 614-21.
20. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258-61.
21. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophagc colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 1994; 179: 1109-18.
22. Bonham CA, Lu L, Li Y, Hoffman RA, Simmons RL, Thomson AW. Nitric oxide production by mouse bone marrow-derived dendritic cells: implications for the regulation of allogeneic T cell responses. Transplantation 1996; 62: 1871-7.
23. Dranoff G, Jaffee E, Lazenby A et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl Acad. Sci. USA 1993; 90: 3539-43.
24. Tao MH, Levy R. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B cell lymphoma. Nature 1993; 362: 755-8.
25. Syrengelas AD, Chen TT, Levy RR. DNA immunization induces protective immunity against B cell lymphoma. Nat. Med. 1996; 2: 1038-41.
26. Hakim I, Levy S, Levy R. A nine-amino acid peptide from IL-1 beta augments antitumor immune responses induced by protein and DNA vaccines. J. Immunol. 1996; 157: 5503-11.
27. Ertl HCJ, Xiang ZQ. DNA vaccines to rabies virus: effects of cytokines on the immune response. In: Norrby E, Brown F, Chancock RM, Ginsberg HS (eds). Vaccine 96. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1996; 83-6.
28. Geissler M, Gesien A, Tokushige K, Wands JR. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 1997; 158: 1231-7.
29. Conry RM, Widera G, LoBuglio AF et al. Selected strategies to augment polynucleotide immunization. Gene Ther. 1996; 3: 67-74.
30. Chow YH, Huang WL, Chi WK, Chu YD, Tao MH. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 1997; 71: 169-78.
31. Abai AM, Kuwahara-Rundell A, Margalith M, Morrow J, Parker SE, Rhodes GH. Coinjection of the genes for interleukin-2 and antigen does not increase the humoral immune response. In: Norrby E, Brown F, Chancock RM, Ginsberg HS (eds). Vaccine 94. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1994; 77-81.
32. Rao JB, Chamberlain RS, Bronte V et al. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines. J. Immunol. 1996; 156: 3357-65.
33. Trinchieri G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995; 13: 251-76.
34. Halpern MD, Kurlander RJ, Pisetsky DS. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell. Immunol. 1996; 167: 72-8.
35. Rakhmilevich AL, Turner J, Ford MJ et al. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl Acad. Sci. USA 1996; 93: 6291-6.
36. Irvine KR, Rao JB, Rosenberg SA, Restifo NP. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 1996; 156: 238-45.
37. Kim JJ, Ayyavoo V, Bagarazzi ML et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 1997; 158: 816-26.